Tenon Medical Inc TNON
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TNON is a good fit for your portfolio.
News
-
Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors
-
Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System
-
Thinking about buying stock in ShiftPixy, Minim, Cardiff Oncology, Laird Superfood, or Tenon Medical?
-
Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial Results
-
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
-
Tenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint Implant
-
Tenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred Stock
-
Tenon Medical Shares Rise 42% After Passing FDA Inspection
Trading Information
- Previous Close Price
- $0.73
- Day Range
- $0.71–0.76
- 52-Week Range
- $0.71–23.00
- Bid/Ask
- $0.71 / $0.76
- Market Cap
- $2.80 Mil
- Volume/Avg
- 28,678 / 278,761
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.05
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 21
- Website
- https://www.tenonmed.com
Valuation
|
Metric
|
TNON
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.51 |
Price/Sales | 0.05 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
TNON
|
|---|---|
Quick Ratio | 0.94 |
Current Ratio | 1.24 |
Interest Coverage | −740.95 |
Quick Ratio
TNON
Profitability
|
Metric
|
TNON
|
|---|---|
Return on Assets (Normalized) | −137.36% |
Return on Equity (Normalized) | −448.89% |
Return on Invested Capital (Normalized) | −320.05% |
Return on Assets
TNON
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Pvcjlzjn | Fzyhtt | $185.4 Bil | |
SYK
| Stryker Corp | Pwpbwnsrmr | Gczwx | $127.7 Bil | |
BSX
| Boston Scientific Corp | Tzswckjc | Cdlmrv | $107.6 Bil | |
MDT
| Medtronic PLC | Dyqvymhj | Jrsmhyw | $105.9 Bil | |
DXCM
| DexCom Inc | Ltvkyvmyw | Vvts | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Prcnbnflhz | Lfblr | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Pxhxvkrch | Kqpq | $24.6 Bil | |
ALGN
| Align Technology Inc | Wdjryls | Vnycrb | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Rhswzlnns | Rwbryc | $18.7 Bil | |
PODD
| Insulet Corp | Trtxzrsw | Pkclzc | $11.6 Bil |